| Literature DB >> 19127076 |
Lorenzo Calligaris1, Gabriele Stocco, Sara De Iudicibus, Sara Marino, Giuliana Decorti, Egidio Barbi, Marco Carrozzi, Federico Marchetti, Fiora Bartoli, Alessandro Ventura.
Abstract
A case of severe hypersensitivity syndrome, triggered by carbamazepine in the presence of a concomitant active human herpes virus (HHV) 6 and 7 infection is described. To further understand the molecular mechanism of this adverse reaction, analyses of the genetic variants of human leukocyte antigen (HLA) and of the epoxide hydrolase gene (EPHX1), previously associated with carbamazepine hypersensitivity, were performed. A lymphocyte transformation test (LTT) was conducted in order to detect drug-specific lymphocytes. In the hypersensitive patient, 2 genetic factors previously associated with intolerance to carbamazepine were detected: the allele HLA-A*3101 and homozygosity for the variant allele of SNP rs1051740 in EPHX1. Drug-specific lymphocytes could be detected by LTT when the HHV was active (positive PCR for viral DNA and increased anti-HHV 6 IgG titer), but not when it was no longer active. In conclusion, we document a case of severe carbamazepine hypersensitivity triggered by viral reactivation in a patient presenting the interaction of 2 unfavorable genetic factors. Copyright 2009 S. Karger AG, Basel.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19127076 DOI: 10.1159/000189202
Source DB: PubMed Journal: Int Arch Allergy Immunol ISSN: 1018-2438 Impact factor: 2.749